Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × Pafolacianine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gastrointestinal Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 Osteosarcoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Appendiceal Neoplasms 1

Interventions

pembrolizumab 23 Paclitaxel 19 Carboplatin 17 Specimen Handling 12 Bevacizumab 11 Letrozole 10 dostarlimab 7 Magnetic Resonance Spectroscopy 7 Biopsy 7 abemaciclib 6 Taxes 6 Fulvestrant 6 Megestrol Acetate 5 Medroxyprogesterone Acetate 5 Cisplatin 5 Blood Specimen Collection 5 trastuzumab deruxtecan 4 olaparib 4 Observation 4 Immunoglobulin G 4 Drug Therapy 4 Doxorubicin 4 palbociclib 3 lenvatinib 3 atezolizumab 3 X-Rays 3 Radiotherapy 3 Progestins 3 Nivolumab 3 Gemcitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07278986 2025-12-12

CYTALUX ISS

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡